ASTRAZENECA PLC - Jan 23, 2025 Form SCHEDULE 13D/A Schedule Report for Cellectis S.A. (CLLS)

Filing Manager: ASTRAZENECA PLC
Reporting Manager: AstraZeneca PLC
Security: Cellectis S.A. Ordinary shares, nominal value of EUR0.05 per ordinary share
Symbol: CLLS
Shares outstanding: 100M shares
Disclosed Ownership: 44M shares
Ownership: 44%
Form type: SCHEDULE 13D/A
Date filed: 1/24/2025, 09:52 AM
Date of event: Jan 23, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
AstraZeneca PLC	44%	44M	44M	0	/s/ Adrian Kemp	Adrian Kemp, Company Secretary	0000901832
AstraZeneca Holdings B.V.	44%	44M	44M	0	/s/ Kamila Kozikowska	Kamila Kozikowska, Director